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Acute lung injury (ALI) is a ma-jor cause of respiratory failureassociated with significantmorbidity and mortality. With
a frequency of 18–79 cases per 100,000
person-years (1–3), ALI is estimated to be
responsible for death in up to 75,000 pa-
tients per year in the United States, the
majority of whom are cared for in non-
academic hospitals (3).
Research on prognostic variables and
scoring systems in ALI is important for
clinical practice and in the development
of research tools (4). Although it is un-
likely that clinical decisions in the inten-
sive care unit (ICU) will be driven solely
by objective prognostic data, this infor-
mation is invaluable in informing clinical
discussions. Accounting for prognostic
variables in clinical trials and adjusting
for their confounding effects in observa-
tional studies are central to valid research
(5, 6).
Investigators confront many choices
in selecting approaches to measuring the
severity of critical illness (7). There are
generic scores, for example, Acute Phys-
iology and Chronic Health Evaluation
(APACHE) or Simplified Acute Physiology
Score (SAPS), developed to assess heter-
ogeneous populations of critically ill pa-
tients. There are also disease-specific
scores, for example, the Injury Severity
Score or the Model End-Stage Liver Dis-
ease Score, developed specifically for
traumatic injury and hepatic failure. One
can use the scores derived from points
assigned to specific variables or use the
scores and other variables along with co-
efficients to develop a predicted risk of
death from a regression model. Typically,
investigators use the scores rather than a
predicted risk of death from a regression
model because the scores are easier to
calculate, perform well compared with
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more complex models, and may be less
subject to secular trends and local prac-
tice variation (4, 8).
Previous work evaluating risk factors
for death in ALI are limited by the inclu-
sion of patients only from referral centers
affiliated with academic institutions (9–
15). Studies exploring prognostic vari-
ables and severity scores in population-
based cohorts of patients with ALI are
limited (1, 2). Recent evidence suggests
that ALI patients cared for in nonaca-
demic hospitals are more numerous, are
older, have greater severity of illness, and
have a different distribution of ALI risk
factors than patients cared for in aca-
demic ICUs (3). At least one large re-
search collaborative studying ALI has
adopted the APACHE III score as a mea-
sure of severity of illness; however, data
on the performance of this measure in a
defined cohort of patients with ALI are
lacking (16). No validated, disease-
specific, severity of illness measure for
ALI exists, and the need for such a score
has not been evaluated.
To address these issues, we used a
population-based cohort of patients with
ALI to determine the predictors of hospi-
tal mortality, to attempt to use this in-
formation to develop a customized sever-
ity of illness measure for ALI, and to
compare generic severity of illness scores
with this customized model. We were not
interested in the performance of the se-
verity of illness regression models or the
predicted risks of death generated by
these models.
MATERIALS AND METHODS
The institutional review board of the Uni-
versity of Washington approved the study.
Study Population
Patients were drawn from the King County
Lung Injury Project (KCLIP) (3). The methods
and results of this project were previously re-
ported (3). Briefly, KCLIP is a large, multi-
center, prospective cohort study of the fre-
quency and outcome of ALI in King County,
WA. All mechanically ventilated patients in 21
hospitals in King County or neighboring
counties that care for King County residents
were screened for ALI during April 1999 to
July 2000 using consensus criteria (17).
Variable Collection and Data
Quality
Pertinent demographic, comorbidity, labo-
ratory, and physiology data were abstracted
from the patients’ computerized or paper
medical record by trained staff using a proto-
col at the time of enrollment. Comorbidities
and operative status were abstracted and
coded using the APACHE II or III methodol-
ogy (18, 19). We did not evaluate treatment-
related variables, such as tidal volume, insulin
infusion, tracheostomy, or corticosteroids for
their potential causal role in ALI outcome,
because these therapies were not strongly sup-
ported by evidence at the time of the study and
they require a completely different approach
to modeling to address confounding and indi-
cation bias. ALI risk factors were gathered
from the medical record at the time of ALI
onset using standard definitions from the 4
days preceding ALI onset (discussed later).
Data from day 3 after ALI onset were prospec-
tively abstracted when available. Day 3 differ-
ences (day 3 minus onset day) in continuous
covariates were calculated when both were
measured and were dichotomized as “im-
proved” or “worsened or no difference.” Vital
status (alive vs. dead) was determined at the
time of hospital discharge. Data quality was
ensured by standardized training of chart ab-
stractors, double data entry, and random qual-
ity checks.
Variable Definitions
Pulmonary. ALI-related variables evalu-
ated for predictive ability included ventilator
variables, arterial blood gases, chest radiogra-
phy severity, and the timing of ALI onset.
Because nearly all patients in this cohort met
diagnostic criteria for multiple risk factors
during the risk period, risk factors for ALI
were modeled using three strategies. First, all
ALI risk factors were included in the model as
dichotomous covariates. Second, we classified
the ALI risk factor as pulmonary/nonpulmo-
nary. Third, we assigned each patient a mutu-
ally exclusive, primary ALI risk factor using a
prespecified algorithm based on the Injury Se-
verity Score, timing of ALI, sepsis criteria, and
presence of other risks. For example, a patient
with an Injury Severity Score 15 developing
ALI within 4 days of injury was assigned a
trauma primary risk even if he or she met
physiologic criteria for sepsis. Alternate risk
factor assignments were explored in sensitivity
analyses.
Physiology. We modeled nonpulmonary
physiology by modeling all nonrespiratory
components of the APACHE III acute physiol-
ogy score (APS) as ordered-categorical vari-
ables. We also modified the APS by subtracting
all respiratory points and included it as a lin-
ear covariate in the logistic equation, which
allowed the pulmonary physiologic variables
to take on unique weighting.
Comorbidity. Comorbidities were modeled
using three strategies. First, all candidate dis-
eases were entered as dichotomous predictors.
Second, the sum-total of the APACHE III
chronic health variables was included as a
single linear covariate. Third, a Charlson co-
morbidity score was entered as a continuous
covariate (20).
Statistical Analysis
Bivariate. Variables were evaluated for
their association with hospital mortality using
chi-square, Student’s t-test, or Wilcoxon’s
rank-sum tests as appropriate (p  .05). We
calculated APACHE II (18), APACHE III (19),
and SAPS II (21) using data from the 24-hr
period surrounding ALI onset. This time point
replicates when severity scores are commonly
calculated in clinical trials. In addition, be-
cause most patients developed ALI within 24
hrs of ICU admission, there were no signifi-
cant differences between severity scores calcu-
lated at ICU admission and ALI onset. Each
point score was calibrated to the KCLIP data
by incorporating it into a separate logistic
model as a single covariate in its best fitting
form with hospital death as the outcome.
SAPS III and the Sequential Organ Failure As-
sessment scores were not evaluated because they
were not calculable in our validation cohort. The
APACHE IV score is identical to APACHE III and
is therefore not presented (22).
Multivariable. For the regression, we ex-
cluded 90 (8%) patients due to missing co-
morbidities (n  19), minute ventilation (n 
69), and PaCO2 (n  2) at the time of ALI onset,
leaving 1,023 evaluable patients. Candidate
variables associated with death on bivariate
analysis (p  .25) were included in a multiple
logistic regression model (23). Multiple vari-
able modeling used a stepwise, backward elim-
ination, forward entering algorithm retaining
significant variables (p  .05). Continuous
variables were modeled using fractional poly-
nomials averting the potential bias involved in
prespecifying the functional form (24, 25). We
compared models using the Akaike informa-
tion criterion and the likelihood ratio chi-
square test as appropriate (23, 26). No first-
order interaction terms were significant. We
calculated predicted probabilities of death by
evaluating the regression equation for each
individual and plotted predicted mortality
against PaO2/FIO2 ratio. We evaluated model
discrimination using the area under the re-
ceiver operating characteristic curve (AUC)
(27). Comparisons of AUCs used the method of
DeLong et al (28). We evaluated model cali-
bration using the Hosmer-Lemeshow chi-
square statistic (p  .05 for all models) (23).
All tests for significance were two-tailed.
Validation
We used the bootstrap to internally vali-
date the final model by sampling with replace-
ment for 1,000 iterations (29). The logistic
model was fit on each bootstrap sample by
repeating the stepwise selection algorithm and
then evaluated on the original cohort to esti-
mate the degree to which the predictive accu-
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racy would deteriorate when the final model is
applied to an independent sample (29). Exter-
nal validation was accomplished by applying
our model to the Acute Respiratory Distress
Syndrome Clinical Network’s (ARDSNet) low
tidal volume study (30).
All analyses were conducted using Stata
version 9.2 (Stata, College Station, TX).
RESULTS
During the KCLIP study period, 1,113
patients met consensus criteria for ALI
and were 15 yrs old. Four hundred
twenty-nine (38.5%) patients died during
the hospitalization in which their ALI was
diagnosed. Median (interquartile range)
time to hospital death after ALI onset in
nonsurvivors was 6 days (2–13 days).
Overall mean (SD) tidal volume on day 3
after the onset of ALI for the cohort was
10.2 (2.6) mL/kg predicted body weight
and 8.5 (2.6) mL/kg measured body
weight, similar to current cohorts de-
scribed in the literature (31, 32). In pa-
tients with recorded plateau pressure
(n  686), 71% had values 30 cm H2O
on the day of ALI onset.
Bivariate Analysis
Patients who were dead at hospital dis-
charge were older than survivors and had
greater severity of illness (Table 1). Pa-
tients dying had statistically significantly
worse respiratory variables, including
greater minute ventilation, higher pla-
teau pressure, lower PaO2/FIO2 ratio,
lower arterial pH, and lower arterial
PaCO2, at the time of ALI onset. The ma-
jority of surviving patients were dis-
charged to skilled nursing or rehabilita-
tion facilities (51%), while fewer were
discharged to home (34%) or to long-
term acute care facilities or other hospi-
tals (13%).
Further details of the mortality and
relative risk of death by ALI risk factor,
chronic comorbidities, physiology, and
hospital and ICU admission source are
shown in Table 2. With the exception of
sepsis, severe trauma, and other/none,
none of the primary ALI risk factors had
statistically significant associations with
hospital death.
Comorbidities significantly associated
with mortality included various malig-
nancies, liver disease, congestive heart
failure, and immunosuppression. Other
subgroups of patients in the cohort iden-
tified at the time of ALI onset with par-
ticularly high and low mortality rates are
shown in Table 2. To contrast the survival
experience of ALI patients at relatively
low (severe trauma) and high risk (oligu-
ric renal failure) of death compared with
the entire cohort, we plotted the time
after ALI diagnosis vs. probability of hos-
pital survival in these groups using the
Kaplan-Meier estimator (Fig. 1).
Day 3 After ALI Onset
Of the 1,113 patients in the cohort,
79% were alive and ventilated on day 3 of
ALI. Of these, 100% had calculable APS,
83% had recorded minute ventilation,
81% had available arterial blood gases,
and 70% had recorded positive end-
expiratory pressure at both ALI onset and
day 3 of ALI. Unadjusted relative risks of
death at hospital discharge in patients
experiencing an improvement in respira-
tory/physiology-related variables by day 3
after ALI onset are shown in Table 3.
Multivariable Analysis
Plateau pressure was not evaluated in
the multivariable model due to missing
values on day 1 (38%). The prognostic
role of body mass index is reported for
this cohort elsewhere (33). Table 4 dis-
plays the variables independently associ-
ated (p  .05) with mortality in the mul-
tiple logistic regression model and the
magnitude of each variable’s contribution
to model fit (chi-square). Age and modi-
fied APS were highly associated with
mortality. Comorbidities remaining sig-
nificant in the multivariable model were
metastatic cancer, hepatic failure, leuke-
Table 1. Baseline characteristics of King County Lung Injury Project Cohort by vital status at hospital
discharge
Variablea




Age, years, median (IQR) 67 (52–77) 59 (46–73) .001




Asian/Pacific Islander 9 5
Other/unknown 15 15
Body mass index 26.7 (7.4) 28.1 (7.8) .01
ALI risk factor (%) .001




APACHE III score 106 (31) 76 (27) .001
APACHE II score 30 (8) 23 (7) .001
SAPS II score 54 (18) 40 (16) .001
ICU days pre-ALI, median (IQR) 1 (1–3) 1 (1–2) .01
Respiratory variables (at ALI onset)
Minute ventilation (L/min) 12 (5) 11 (4) .001
Plateau pressure (mm Hg) 27.1 (8.2) 25.5 (7.2) .01
PaO2/FiO2 ratio (mm Hg) 140 (67) 161 (66) .001
pH 7.35 (.12) 7.39 (.10) .001
PaCO2 (mm Hg) 40 (11) 42 (11) .001
Type of operation (%) .003
Emergent 9 15
Non-emergent 7 11
No operation 84 74
Disposition (%)
Skilled nursing or rehab facility – 51
Home – 34
Hospital or LTAC – 13
Other/unknown – 3
ICU, intensive care unit; IQR, interquartile range; ALI, acute lung injury; APACHE, Acute Physi-
ology and Chronic Health Evaluation; SAPS, Simplified Acute Physiology Score; LTAC, long-term
acute care facility.
aData were missing for body mass index in 288 (26%) patients; severity of illness measures, 19
(0.7%); plateau pressure, 427 (38%); pH and PaCO2, 22 (2%); minute ventilation 69 (8%).
bNumbers
reflect mean (SD) unless otherwise noted. Percentages may not add to 100 due to rounding.
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mia, lymphoma, and congestive heart fail-
ure. Patients admitted from the ward to
the ICU had an odds ratio of 1.55 (95%
confidence interval 1.06–2.28) compared
with those admitted from the emergency
room. Patients developing ALI after 48
hrs in the ICU had an 82% greater odds of
death (odds ratio 1.82, 95% confidence
interval 1.32–2.50) compared with those
developing ALI within the first 48 hrs
independent of other factors. The PaO2/
FIO2 ratio was best modeled using a frac-
tional polynomial. The independent odds
and predicted probability of death in-
creased dramatically below PaO2/FIO2
100 mm Hg (Fig. 2). Chest radiography
severity and ALI risk factor, regardless of
coding method, were not associated with
mortality after adjustment for other fac-
tors, including admission source and re-
spiratory variables. The Hosmer-Leme-
show goodness-of-fit statistic for this
customized model showed no evidence of
lack of fit (28  11.15, p  .19).
The AUCs for the customized model
and other severity of illness measures are
shown in Table 5. The customized model
(Table 4) had statistically better mortality
discrimination compared with APACHE
II, APACHE III, and SAPS II. The AUC for
APACHE III was superior to APACHE II
(p  .004) and SAPS II (p  .001). After
internal validation using the bootstrap,
the AUC for the customized model
dropped to 0.79 (95% confidence interval
.76–.81). External validation through ap-
plication of the customized model to the
ARDSNet low tidal volume study (n 
886) resulted in an AUC of .71 (.67–.74)
compared with .70 (.67–.74) for APACHE
III. This difference did not reach statisti-
cal significance (p  .64). Calibration of
the customized model to the ARDSNet
cohort showed adequate goodness of fit
(28  8.53, p  .38) as well as for
APACHE III (28  9.45, p  .31).
DISCUSSION
In this population-based cohort of pa-
tients with ALI, the primary determi-
nants of hospital mortality were similar
to those seen in other populations of crit-
ically ill patients. Acute physiologic de-
rangement, age, severe chronic comor-
bidities, ICU admission source, and
duration of ICU stay before ALI onset
were all important independent predic-
tors of mortality. Certain subgroups, in-
cluding patients with coma, liver dys-
function, renal dysfunction, shock, and
profound hypoxemia, have particularly
Table 2. Mortality rate and relative risk of death for patients with and without specific ALI risk factors,






of Deathb 95% CI% 95% CI
Entire cohort 1113 39 36–41 – –
ALI risk factor
Severe sepsis
No sepsis 312 29 24–34 1.00 Sepsis Referent
Non-pulmonary 76 54 42–65 1.87 1.43–2.45
Pulmonary 416 43 38–47 1.48 1.20–1.81
Mixed 309 39 34–45 1.36 1.09–1.70
Trauma 65 23 14–35 .58 0.37–0.92
Pancreatitis 32 41 24–59 1.06 .69–1.62
Witnessed aspiration 32 38 21–56 .97 .62–1.53
Pneumonia (non-septic) 21 14 3–36 .37 .13–1.05
Massive transfusion 15 40 16–68 1.03 .56–1.94
Overdose 14 29 8–58 .74 .32–1.69
Post-cardiac bypass surgery 10 20 3–56 .52 .15–1.79
Other/none 123 28 21–37 .71 .53–0.96
Chest radiograph
AECC definition 741 35 32–39 1.00 Referent
50% alveolar opacity in 3
or more quadrants
372 45 40–50 1.27 1.09–1.47
Comorbidity
Leukemia or lymphoma 32 75 57–89 1.99 1.61–2.47
Metastatic cancer 58 69 55–80 1.86 1.54–2.25
Chronic renal insufficiency 42 60 43–74 1.57 1.21–2.03
Immunosuppressed 95 56 45–66 1.50 1.23–1.83
HIV positive 27 56 35–75 1.45 1.03–2.05
Liver failure or cirrhosis 96 53 43–63 1.42 1.16–1.74
Congestive heart failure 169 47 40–55 1.27 1.06–1.52
Non- metastatic cancer 163 45 38–53 1.21 1.00–1.46
Diabetes mellitus 237 39 33–46 1.02 .85–1.22
Physiologyc
Highest APS quartile 273 66 60–71 2.20 1.92–2.52
Vasopressor use 2 hours 316 56 51–62 1.78 1.55–2.05
GCS 8 402 53 48–58 1.72 1.49–1.99
Shock 487 50 45–54 1.66 1.43–1.93
& GCS 8 183 63 56–70 1.87 1.62–2.16
& oliguric renal failure 65 72 60–83 1.97 1.66–2.34
Oliguric renal failure 89 69 58–78 1.90 1.61–2.23
& GCS 8 48 79 65–90 2.15 1.82–2.53
& bilirubin 2.0 mg/dL 15 80 52–96 2.10 1.62–2.74
Bilirubin 2.0 mg/dL 96 64 53–73 1.75 1.47–2.08
& GCS  8 43 74 59–86 2.00 1.65–2.42
Arterial pH 7.20 76 66 54–76 1.80 1.50–2.15
Minute ventilation 20 L/min 43 65 49–79 1.71 1.36–2.16
PaO2/FIO2 100 mm Hg 307 50 44–56 1.46 1.26–1.69
& shock 164 58 50–66 1.64 1.40–1.92
& oliguric renal failure 28 71 51–87 1.89 1.48–2.42
PaCO2 60 mm Hg 69 22 13–33 .55 .35–.86
Hospital admission source (%)
Home 838 39 36–42 1.00 Referent
Other hospital 95 33 23–42 .84 .62–1.13
Skilled nursing/other facility 161 42 34–49 1.07 .87–1.31
ICU admission source
Emergency room 496 35 31–39 1.00 Referent
Ward 272 52 46–58 1.48 1.25–1.74
Direct 62 47 34–60 1.33 1.00–1.78
Operating room/angiography 253 30 24–36 .86 .69–1.07
Other 11 36 11–70 1.04 .47–2.29
Other variable combinations
Any malignancy 242 54 47–60 1.56 1.34–1.81
Age 45 and trauma as ALI risk 37 16 6–32 .41 .20–.86
Age 65 years 499 46 41–50 1.39 1.20–1.62
& PaO2/FIO2 100 mm Hg 119 64 55–72 1.80 1.53–2.10
& highest APS quartile 114 69 60–78 1.97 1.70–2.28
Age 80 years 153 51 43–59 1.39 1.17–1.66
& PaO2/FIO2 100 mm Hg 30 77 58–90 2.04 1.65–2.52
& highest APS quartile 33 73 54–87 1.93 1.54–2.51
ALI, acute lung injury; AECC, American European Consensus Conference; CI, confidence interval;
HIV, human immunodeficiency virus; APS, APACHE III acute physiology score; GCS, Glasgow coma
score.
aResults available for 1094 patients except for: minute ventilation (n  1025); age, PaO2:FiO2, ALI
risk factor, chest radiograph (n  1113); pH, PaCO2 (n  1091).
bRelative risk comparing N with
variable to all other patients unless otherwise noted. cShock defined as mean arterial pressure 60
mm Hg at any point during onset day. Oliguric renal failure defined as the combination of urine output
500 cc in a 24-hr period and serum creatinine 2.0 mg/dl during onset day.
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poor prognosis; however, no risk factors
either alone or in combination sufficiently
identified patients whose care was futile.
Among patients who survived to and were
intubated on day 3, those with improving
physiology were less likely to die. In exter-
nal validation, a regression model using the
generic APACHE III score recalibrated to
this cohort performed as well as a custom-
ized model that incorporated ALI-specific
variables, including risk factor for ALI and
pulmonary physiology.
Consistently identified independent
predictors of mortality in previous stud-
ies of ALI include age (9, 34), nonpulmo-
nary organ dysfunction (12, 14), and liver
disease (9, 34). Additional predictors of
mortality, such as body mass index (33,
35), pulmonary deadspace fraction (13),
immunosuppression (14), ALI risk factor
(10, 11, 15), and ventilator days before
ALI (9), have also been identified, yet
many were not isolated as independent
predictors in subsequent studies. Previ-
ous studies examining predictors of mor-
tality evaluated patients from tertiary
care academic centers with few focusing
on population-based cohorts (1, 34). We
determined that nonpulmonary organ
dysfunction; age; history of leukemia,
congestive heart failure, or hepatic fail-
ure; arterial pH; ICU admission source;
ICU stay prior to ALI onset 48 hrs;
minute ventilation; and PaCO2 are all in-
dependently predictive of mortality.
These results are important because they
demonstrate that in a population-based
cohort of patients with ALI, predictors of
mortality are similar to large heteroge-
neous cohorts of patients with critical
illness from around the world.
Contrary to some other studies, we did
not find that ALI risk factor was an inde-
pendent predictor of death (10, 11, 15).
This was true regardless of the method
that we used to code risk factor (primary
risk, any risk, or pulmonary/nonpulmo-
nary risk). Although ALI risk factor was
associated with death on bivariate analy-
ses, it dropped out of the multivariable
analysis. Other variables in the model,
including acute physiology, oxygenation,
ICU admission source, and comorbidity,
likely capture the information provided
by the risk factor for ALI. This finding
agrees with the only other population-
based study to rigorously evaluate the
association between ALI risk factor and
death (34).
We determined that the PaO2/FIO2 ra-
tio at ALI onset was independently asso-
ciated with mortality. This finding dis-
agrees with most (13, 14, 34, 36) but not
all (1, 37) previous studies in ALI. The
discrepancy between our results and
those of others may result from the
power of this large ALI cohort to detect
such an effect, our richer PaO2/FIO2 mod-
eling strategy using fractional polynomi-
als (25, 38, 39), our use of a modified APS
to prevent collinearity between physiol-
ogy modeling and oxygenation (13, 14,
34), and underlying differences between
KCLIP and cohorts in previous studies. In
the analysis by Luhr and colleagues (1) of
221 patients with acute respiratory dis-
Figure 1. Kaplan-Meier estimates of hospital survival among 65 patients with severe trauma and 89
patients with oliguric renal failure (defined as urine output 500 mL in a 24-hr period and serum
creatinine 2.0 mg/dL) at onset of acute lung injury (ALI) compared with 1,113 patients in the entire
cohort. Curves are not mutually exclusive. Patients were censored at hospital discharge. Time is
truncated at 120 days.
Table 3. Relative risk (RR) of death at hospital discharge in patients experiencing improvement in
respiratory/physiologic variables by day three post-acute lung injury onset




Mortality RR of Death
% 95% CI Point 95% CI
APS
Lower 581/876 33 29–37 .77 .64–.91
Greater or no difference 295/876 43 38–49 1.00 Referent
PaO2/FIO2
Greater 482/710 32 28–36 .74 .61–.90
Lower or no difference 228/710 43 35–50 1.00 Referent
Minute ventilation
Lower 338/730 36 31–42 .89 .74–1.07
Greater or no difference 392/730 41 36–46 1.00 Referent
PEEP
Lower 85/615 32 22–43 .79 .57–1.10
Greater or no difference 530/615 40 36–45 1.00 Referent
PaCO2
Greater 300/709 33 27–38 .88 .72–1.08
Lower or no difference 409/709 37 32–42 1.00 Referent
APS, Acute Physiology and Chronic Health Evaluation III acute physiology score; CI, confidence
interval; PEEP, positive end-expiratory pressure.
aEach variable represents the day three value minus the day one value dichotomized at zero.
“Lower” denotes negative difference. “Greater” denotes positive difference. Patients with no difference
are grouped in the referent category for each variable.
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tress syndrome identified through a pop-
ulation-based screening of patients in
Scandinavia, those with a PaO2/FIO2 ratio
100 mm Hg at enrollment had an odds
of death 26% lower than those with PaO2/
FIO2 100 mm Hg. This finding, like
ours, was independent of age, ALI risk
factor, and physiologic perturbation. In
contrast to a subsequent analysis by Luhr
and colleagues (34), we found that pa-
tients whose oxygenation improved by
day 3 of ALI were at lower odds of death.
Our results also support the hypoth-
esis that hypercapnia may be protective
or that hypocapnia is injurious in ALI.
Each 5-mm Hg increase in the PCO2 was
associated with a 10% reduction in the
odds of hospital death independent of
pH, minute ventilation, and other fac-
tors. Although these results corrobo-
rate prior work (40), our a priori anal-
ysis plan did not seek to exhaustively
evaluate this association; thus, we did
not control for plateau pressure or
other variables that might specifically
confound this association.
Our results illustrate the considerable
overlap between the predictors of death
in ALI and predictors of death in general
ICU populations throughout the world.
Additional significant variables in our
multivariable model, including arterial
pH, leukemia, admission source to the
ICU, and duration of stay before ALI on-
set, are not well-described predictors of
death in ALI patients. These variables,
however, are well-known predictors of
death in the general ICU population (22,
41). In fact, with the exception of minute
ventilation, all of the predictors of mor-
tality in our multivariable model were
previously described in at least one of the
three largest current ICU severity of ill-
ness measures (19, 22, 41).
There are several reasons why the pre-
dictors of death in ALI are similar to
those in the general ICU population.
First, ALI is a syndrome resulting from a
heterogeneous group of insults. Typical
ALI cohorts include not only young
healthy patients with trauma but also el-
derly patients with pneumonia or sepsis
(30, 42). The APACHE III prognostic
equation was derived on a heterogeneous
group of 17,000 critically ill patients
that included 70 ICU admission diag-
noses (19), and SAPS III was derived us-
ing 16,000 patients in 303 ICUs across
five continents. Both of these severity
measures incorporated ALI patients dur-
ing their derivation. In their population-
based study of respiratory failure, Luhr
and colleagues (34) determined that non-
postoperative mechanical ventilation, in
the absence of ALI, is associated with a
mortality of 41%, which is similar to our
reported mortality of 38.5% in ALI. More-
over, experts’ ability to clinically separate
ALI from other heterogeneous causes of
respiratory failure is limited (34, 43).
Given the heterogeneous nature of ALI
and acute respiratory failure, it is under-
standable that the predictors of mortality
given by these severity scores would over-
lap with those in ALI.
Second, patients who develop acute
lung injury do not often die of hypoxic
respiratory failure but rather die as a re-
sult of their underlying disease or, more
important, as a result of withdrawal from
mechanical ventilation (44). As we de-
scribed here, the majority of variables in
our multivariable model simply reflect an
ICU patient’s severity of illness. There-
fore, our inability to isolate ALI-specific
clinical predictors of death in this large
cohort may reflect the fact that in a broad
population base, none exist.
Third, our results show that APACHE
II and SAPS II do not discriminate be-
tween patients who will live and those
who will die as well as the APACHE III
score or our customized model. This re-
sult has important implications to the
scientific community. Although ARDS-
Net has adopted APACHE III as the pre-
ferred severity of illness measure gath-
ered during its studies, the use of
APACHE II and SAPS II in ALI research
remains common (35, 45, 46). The im-
portance of the small improvement in
discrimination seen with the APACHE III
score over APACHE II or SAPS II is un-
known. However, since the APACHE III
score is openly available and easily calcu-
lable, investigators planning studies of
ALI should consider using it over other
severity of illness measures. Risk adjust-
ing with alternative scores may not fully
capture a patient’s severity of illness and
could lead to residual confounding.
There are a number of limitations to
our analysis. First, our patient population
was gathered during the year 1999–2000,
before publication of a landmark study
showing that low tidal volume ventilation
reduced mortality in ALI (30). Predictors
of mortality in ALI patients ventilated
Table 4. Multivariate model with adjusted odds ratios (OR) and 95% confidence intervals (CI) for
independent predictors of mortality in King County Lung Injury Project
Variable Adjusted OR 95% CI Covariate 2a
Modified acute physiology score (per point) 1.03 1.02–1.04 100.11
Age (per 10 years older) 1.25 1.14–1.37 23.31
Metastatic tumor 4.94 2.51–9.75 23.07
Hepatic failure 3.06 1.46–6.40 9.03
Lymphoma 4.22 1.21–14.71 5.29
Leukemia 9.82 1.87–51.70 9.63
Congestive heart failure 1.77 1.17–2.66 7.47
Admission source to ICU 7.05





Time in ICU prior to ALI onset (hours) 14.01
48 1.00 Referent
48 1.82 1.32–2.50
Arterial pH (per 0.1 more alkalotic) .81 .68–.96 5.82
PaO2/FiO2 ratio
a,b Reference point 17.41
1–100 50 3.04 1.74–5.31
101–150 125 1.15 1.07–1.23
151–200 175 1.05 1.02–1.08
201–300 250 1.00 Referent
PaCO2 (per 5-mm Hg increase) .90 .83–.99 5.2




ALI, acute lung injury; ICU, intensive care unit; OR, operating room.
aLikelihood ratio 2 statistic reflects relative contribution of the covariate to the overall model fit.
bModeled as a function of P/F ratio ((P/F 100)∧2)  0.426) as a continuous covariate using fractional
polynomials. The odds ratio (OR) for each category was calculated by comparing the midpoint of the
given range (reference point) to the midpoint of the last category (P/F 250).
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with this strategy may differ than those in
our study. However, recent studies con-
tinue to suggest that there is limited up-
take of low tidal volume ventilation in
patients with ALI, and tidal volumes in
this cohort mimic those seen in other
more recent cohorts of patients with ALI,
suggesting generalizability of our find-
ings (31, 32).
Second, KCLIP was designed to gather
epidemiologic data routinely captured in
critically ill patients. Therefore, we were
unable to assess the value of novel pre-
dictors not currently collected by inten-
sivists in all patients, for example, pulmo-
nary dead space (13), positive end-
expiratory pressure responsiveness (42),
and various biological markers (6). Our
customized model was only able to im-
prove upon APACHE III to the extent that
the additional comorbidities and respira-
tory-specific variables gathered during
the study contribute to prediction of
death. In addition to examining generic
ICU severity of illness scoring, future re-
search on prognostic modeling in pa-
tients with ALI should explore novel ge-
netic and physiologic markers and other
biomarkers and pay specific attention to
how these evolve over time.
Third, because we used patients aris-
ing from a population base to determine
the predictors of mortality in ALI, our
ability to determine academic and com-
munity-specific predictors of death was
limited. Academic and community hos-
pitals care for different patient popula-
tions, and different patient populations
generate different risk equations. Nev-
ertheless, we believe that our predictors
generalize to the entire spectrum of
patients with ALI.
Fourth, we were unable to evaluate
some potentially important predictors be-
cause they were not collected routinely in
this cohort. Plateau pressure, a complex
variable linked to physician management
decisions as well as underlying physiol-
ogy, was not incorporated into the model
because it was missing in 38% of the
cohort on day 1. We were also unable to
evaluate recently developed severity of ill-
ness scores, such as SAPS III, which may
outperform both APACHE III and our
model.
Figure 2. Relationship between PaO2/FIO2 (P:F) ratio at onset of acute lung injury (ALI) and risk-
adjusted odds and probability of hospital death. Risk adjustment variables included in the model are
modified acute physiology score, age, comorbidities (leukemia, lymphoma, metastatic cancer, hepatic
failure, congestive heart failure), duration of intensive care unit stay before ALI, location before
intensive care unit admission, arterial pH, minute ventilation, and PaCO2. A, the solid line indicates the
point estimate for the odds ratio for each P:F on the x-axis. The gray region indicates the 95%
confidence interval for the point estimate. The risk-adjusted odds of death are presented for each P:F
relative to the midpoint of the reference category (P:F 201–300 mm Hg). Area above the horizontal line
indicates increased hospital mortality relative to patients with P:F of 250 mm Hg and below the
horizontal line indicates lower hospital mortality. B, the line represents a smoothed estimate of the
predicted probability of hospital death for the cohort. Smoothing achieved using locally weighted least
squares (lowess).
Table 5. Comparison of area under the receiver
operating characteristic curve (ROC) for custom-
ized model and other severity of illness measures
prior to validation
Scorea
Area Under the ROC
Curve
Original 95% CI
Customized modelb .81 .78–.83
APACHE III .77c .75–.80
APACHE II .75c .72–.78
SAPS II .74c .71–.77
aScores calculated from the 24-hr period sur-
rounding day of ALI onset. bRefers to the model
shown in Table 4. cp  0.001 compared to cus-
tomized model.
ALI, acute lung injury; APACHE, Acute Phys-
iology and Chronic Health Evaluation; CI, confi-
dence interval; SAPS, Simplified Acute Physiol-
ogy Score.
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CONCLUSIONS
We found that there is considerable
overlap between the predictors of mortal-
ity in patients with ALI and predictors in
general ICU patients. In addition,
APACHE III is an appropriate risk adjust-
ment tool for patients with ALI. Future
attempts to develop a severity of illness
measure in ALI should incorporate novel
clinical, biological, or genetic data.
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